NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL

Introduction. Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as an important and common public health problem that can lead to cirrhosis and hepatic failure (hepatocellular carcinoma – HCC). It may be the most prevalent liver disease. However knowledge of the epidemiology is li...

Full description

Bibliographic Details
Main Author:	D. V. Blinov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-12-01
Series:	Фармакоэкономика
Subjects:	epidemiology nafld non-alcoholic fatty liver disease nash non-alcoholic steatohepatitis hepatocellular carcinoma hcc prevalence
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/110

Similar Items

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lourianne Nascimento CAVALCANTE, et al.
Published: (2022-11-01)

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results
by: V. T. Ivashkin, et al.
Published: (2015-12-01)

Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease
by: Ye Eun Cho, et al.
Published: (2023-03-01)

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
by: Deniz Tümen, et al.
Published: (2022-12-01)

Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease
by: HAO Dandan, ZHANG Lei, BAI Chunying
Published: (2023-08-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena
by: Aamir Bashir, et al.
Published: (2022-06-01)

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Nelson Kei, et al.
Published: (2023-09-01)

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
by: Christoph Roderburg, et al.
Published: (2023-04-01)

Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease
by: Yang Xiao, et al.
Published: (2021-08-01)

Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis
by: Nicha Wongjarupong, et al.
Published: (2017-12-01)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
by: Francesca Cainelli, et al.
Published: (2020-02-01)

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients
by: Yan Huang, et al.
Published: (2022-01-01)

Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis
by: Shui-Xian Du, et al.
Published: (2017-12-01)

Gut microbiome in non-alcoholic fatty liver disease
by: Anastasios Mpountouridis, et al.
Published: (2025-01-01)

Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review
by: Yalan Deng, et al.
Published: (2024-09-01)

Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
by: Francisco Idalsoaga, et al.
Published: (2020-08-01)

Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
by: Sukrit Kanchanasurakit, et al.
Published: (2022-05-01)

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?
by: Ju Hyun Shim
Published: (2020-04-01)

Can Walnut Serve as a Magic Bullet for the Management of Non-Alcoholic Fatty Liver Disease?
by: Mi-Young Kim, et al.
Published: (2020-12-01)

Involvement of a periodontal pathogen, <it>Porphyromonas gingivalis </it>on the pathogenesis of non-alcoholic fatty liver disease
by: Yoneda Masato, et al.
Published: (2012-02-01)

Pediatric non-alcoholic fatty liver disease
by: Delvin Edgard, et al.
Published: (2015-01-01)

The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies
by: Umar Hayat, et al.
Published: (2021-01-01)

Vitamins and non-alcoholic fatty liver disease: A molecular insight
by: Sana Raza, et al.
Published: (2021-06-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease
by: Veronika Zubáňová, et al.
Published: (2021-04-01)

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis
by: Somaya Albhaisi, et al.
Published: (2023-08-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease
by: Carlo Smirne, et al.
Published: (2020-11-01)

Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLD
by: Victoria Svop Jensen, et al.
Published: (2021-02-01)

The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-12-01)

Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

Preventative and Therapeutic Effects of Astaxanthin on NAFLD
by: Nor Hafiza Sayuti, et al.
Published: (2023-08-01)

NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
by: Stephen Caldwell
Published: (2017-06-01)

Editor’s Pick: Non-Alcoholic Fatty Liver Disease – Changing the Prevalence of Liver Cancer?
by: Benedetta Campana, et al.
Published: (2015-01-01)

Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)